x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Decera Clinical Education Infectious Disease Podcast

Decera Clinical Education

Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Decera Clinical Education. Gain practical strategies and earn CME/CE credit for selected episodes.

education courses

All Episodes

00:10:16

Barriers and Solutions to Expanding PrEP Uptake: PrEP...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake in the context of racial inequities, specifically for Black and Latinx communities. His discussion includes: Inequities in PrEP uptake in Black and Hispanic and Latinx people compared with White peopleStructural

en

00:09:32

Linkage to Care After HBV Diagnosis in Asian...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” Hear from Thuan Vu, MD, as he discusses linkage to care after HBV diagnosis in Asian communities from a provider’s perspective. And listen to discussions with Jennifer Wild, MSN, BSN, RN, OCN, and Melinda Tran as they consider his story from a patient advocacy point of view.Topics include barriers to linkage to care like social stigma, lack of

en

00:13:58

Cutting-Edge Concepts in HIV Care: PrEP

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

In this episode, Paul E. Sax, MD, discusses the latest recommendations and options for HIV pre-exposure prophylaxis (PrEP), including:CDC PrEP guideline 2021 updates for oral PrEPThe ANRS IPERGAY study: on-demand oral emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF) PrEP in men who have sex with men who are at high risk for HIV infectionA review of the HPTN 083 and 084 studies: efficacy and safety of long-acting (LA) injectable cabotegravir (CAB) vs daily oral FTC/TDF for PrEP1-year follow-up

en

00:19:31

Cutting-Edge Concepts in HIV Care: Long-Acting Therapies

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

In this episode, Paul E. Sax, MD, discusses long-acting (LA) injectables for HIV treatment, including: Guidance on the use of LA cabotegravir (CAB) + rilpivirine (RPV)Risk factors for virologic failure of LA CAB + RPVThe ATLAS-2M studyCombined clinical trials of LA CAB + RPVPractical considerations for LA CAB + RPVImplementation of LA CAB + RPV Switching to LA CAB + RPV without an oral lead-in, including a discussion of the FLAIR extension studySupporting candidates for LA antiretroviral therapy

en

00:20:09

Ending the HIV Epidemic: Persistence on ART

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes:WHO Global Health Strategy on HIVLongitudinal HIV care trajectoriesPromotion of successful care and antiretroviral therapy (ART) adherenceDifferentiated service deliveryImproving care and ART adherence in high-risk groupsPatient perspectives on ART persistence Presenter:Linda-Gail Bekker,

en

00:12:03

Treatment Barriers in Asian Communities in the US

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

This episode is part of a larger discussion that comes from “Partnering With Patients: Overcoming Barriers to HBV Care in Asian Communities in the US.” First, Melinda Tran discusses treatment and retention of HBV care in Asian Communities in the US with Jennifer Wild, MS, BSN, RN, OCN, and Thuan Vu, MD. Their conversation offers an interesting mix of insights from the point of view of patient advocates and healthcare providers.Topics include barriers to treatment—like a lack of insurance coverage

en

00:18:13

HBV Treatment and Retention in Care Among African...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

Patient advocate Bright Ansah shares some issues he encountered while seeking treatment after his diagnosis with HBV, including limited follow-up on lab results and a lack of compassion from his healthcare providers, and rushed health appointments.Bright’s story opens up a conversation about broader concerns about HBV treatment and retention in care with Janet Afoakwah and William Amiteye, fellow patient advocates on the panel, and Patricia D. Jones, MD, MSCR, who offers a healthcare provider’s

en

00:12:45

HBV Screening and Diagnosis Among African Communities...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/14

Listen as patient advocate William Amiteye uses his own experience as a Tanzanian immigrant to discuss important barriers to effective HBV screening and diagnosis, including limited knowledge about HBV from his healthcare providers, a lack of compassion toward his diagnosis from those same providers, and a limited awareness of HBV from patients in general.His story opens up an interesting and important discussion with another patient advocate on the panel, Janet Afoakwah, and Patricia D. Jones, MD,

en

00:07:52

Barriers and Solutions to Expanding PrEP Uptake:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/07

This is 1 of 6 short episodes taken from a webinar on barriers and solutions to expanding pre-exposure prophylaxis (PrEP) uptake in the comprehensive program “Contemporary HIV Treatment and Prevention 2022.” In this episode, Timothy J. Wilkin, MD, MPH, discusses barriers to PrEP uptake for adolescents. His discussion includes: How PrEP is underused in adolescents and young adultsHealthcare professional barriers to provision of PrEP for adolescentsA systematic review and meta-analysis of adherence to

en

00:18:53

ART Safety Considerations in Aging Patients With HIV

Decera Clinical Education Infectious Disease Podcast ·

2022/11/02

In this episode, hear Marta Boffito, MD, PhD, FRCP, and Julian Falutz, MD, FRCPC, discuss their approach to minimizing antiretroviral (ARV)-related intolerances in older patients with HIV, including:Consequences of polypharmacyDeprescribing ARV and non-ARV medicationsComplications associated with aging (eg, geriatric syndromes such as falls, frailty, multimorbidity)Mediations to avoid, such as anticholinergic medications, to minimize drug–drug interactions and risk of developing geriatric

en

00:44:39

What Patients Want in HIV Treatment and Prevention:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/02

In this episode, Marc Thompson and Tristan J. Barber, MA, MD, FRCP, discuss some of the barriers to genuinely patient-centered HIV care in the United Kingdom and offer calls to action for healthcare professionals for responding to patient preferences. They discuss barriers to HIV testing and effectively communicating the benefits of testing to disparate communities. They also talk through the difficulties in maintaining patient engagement in HIV care and the value of using peer support workers in

en

00:13:34

If RSV Vaccines Are Approved for Older Adults, What’s...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/02

An RSV vaccine, if approved, may reduce disease burden in older adults. In this recap of the most common questions from a symposium at the Family Medicine Experience 2022 conference, listen as we discuss when an RSV vaccine may be approved and how to overcome barriers to the implementation of vaccines for older adults in primary care settings.Hear answer to questions such as:When might potential RSV vaccines be available, and when might the Advisory Committee on Immunization Practices make

en

00:38:19

What Patients Want in HIV Treatment and Prevention:...

Decera Clinical Education Infectious Disease Podcast ·

2022/11/01

In this episode, Deondre Moore and Samantha V. Hill, MD, MPH, discuss some of the barriers to genuinely patient-centered HIV care in the United States and offer calls to action for healthcare professionals for responding to patient preferences. They talk through some of the barriers that patients face, from struggling with unfamiliar medical terminology, to healthcare professional biases, to more structural problems like housing and food scarcity. They also discuss strategies that healthcare

en

00:05:57

Addressing Barriers to PrEP Uptake Among Black...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/31

In this episode, Samantha Strong, PharmD, BCACP, AAHIVP, CDCES, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black cisgender women, including:Racial inequities in PrEP accessAddressing barriers to PrEP for cisgender women such as lack of education and awareness, low perceived risk of HIV, healthcare professional bias, and medical mistrustClosing the PrEP gap through education, normalizing sexual health conversations, and decreasing stigma to empower womenSamantha Strong, PharmD,

en

00:06:04

Addressing Barriers to PrEP Uptake Among Black MSM

Decera Clinical Education Infectious Disease Podcast ·

2022/10/27

In this episode, Latesha Elopre, MD, MSPH, discusses closing the HIV pre-exposure prophylaxis (PrEP) gap for Black men who have sex with men (MSM), including:Racial inequities in PrEP accessConsidering strategies to address barriers to PrEP uptake and persistence among Black MSMConsidering individualized PrEP optionsOn-demand oral emtricitabine/tenofovir disoproxil fumarate (2:1:1)Injectable cabotegravirEmpowering patients to take control of their PrEP care by providing choices for optimal

en

00:10:18

London Perspective: Comorbidity and Adherence...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/27

When it comes to managing older adults with hepatitis B virus (HBV), what comorbidity, comedication, and adherence issues should be considered?Listen as Graham R. Foster, FRCP, PhD, discusses these considerations and more for strategizing the monitoring and treatment of older adults with HBV. Presenter: Graham R. Foster, FRCP, PhDProfessor of HepatologyThe Liver UnitConsultant HepatologistQueen Mary University of LondonLondon, United KingdomLink to full program:https://bit.ly/3fg9fwB

en

00:07:08

Switching ART in a Virologically Suppressed Person...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/20

In this episode, Timothy J. Wilkin, MD, MPH, provides a case-based overview of switching antiretroviral therapy in a patient with viral suppression on their current regimen who has a history of virologic failure with drug-resistance mutations. Key findings from 2 relevant studies—the SWITCHMRK trial and Study 380-4030—are reviewed. The case discussion also highlights several other challenges that can be encountered in the switch setting, including incomplete immune recovery, comorbidities, and

en

00:57:26

Answering the Questions on Switching ART With...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/19

In this episode, Tristan J. Barber, MA, MD, FRCP, and Darcy Wooten, MD, discuss switching ART with virologic suppression, including:Switching with prior or unknown resistanceData on switching to BIC/FTC/TAF with a preexisting M184V/I mutation from a pooled analysis of 6 phase III studiesThe impact of baseline resistance on outcomes following a switch to BIC/FTC/TAF in Black PWH from the BRAAVE 2020 studyA post hoc analysis of the SALSA study of DTG/3TC outcomes at Week 48 by baseline resistanceData

en

01:18:30

All Eyes on ExPEC: A Major Driver of Invasive Disease...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/18

In this episode, Lilian Abbo, MD, FIDSA; Julie Ann Justo, PharmD, MS; and David van Duin, MD, PhD, FIDSA, FAST, discuss key concepts about extraintestinal pathogenic Escherichia coli, including:Diverse strains and virulence factors associated with invasive diseaseAntimicrobial resistance profiles seen in clinical practiceVarious disease manifestationsPrevalence and burden of invasive infectionsPopulations at riskRisk factors for multidrug-resistant strainsEmerging vaccine technologiesActive clinical

en

00:13:06

Meningococcal Disease: A Deadly, Unpredictable but...

Decera Clinical Education Infectious Disease Podcast ·

2022/10/12

In this podcast, Gary S. Marshall, MD, summarizes the burden of meningococcal disease and the importance of immunization, including: The unpredictability and severity of meningococcal diseaseDifferences between meningococcal serogroups and available vaccines Current meningococcal vaccine recommendations, distinguishing between routine vs shared clinical decision-making recommendations Vaccine recommendations in high-risk populations Use of immunization platforms to help complete age-appropriate

en

497 results

Similar Podcasts

Science Talk

Albert Einstein College of Medicine

五分钟心理学

柠檬心理

Daily Facts

Amalia Dupray and Montgomery Jones.

Les dents et dodo

BFMTV

Veterinary Clinical Podcasts

The Royal Veterinary College